4.6 Article

Three-Country Snapshot of Ornithine Transcarbamylase Deficiency

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders

Nicola Longo et al.

Summary: This study confirms the safety and efficacy of GPB in UCD patients aged 0-2 months who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. In this population, GPB undergoes intestinal hydrolysis with no accumulation.

MOLECULAR GENETICS AND METABOLISM (2021)

Review Physiology

Ornithine Transcarbamylase - From Structure to Metabolism: An Update

Morgane Couchet et al.

Summary: Ornithine transcarbamylase (OTC) is a widely distributed enzyme in organisms, catalyzing the production of L-citrulline and playing a crucial role in the urea cycle. OTC is mainly expressed in the liver and intestine in mammals, influencing amino acid homeostasis significantly.

FRONTIERS IN PHYSIOLOGY (2021)

Article Endocrinology & Metabolism

Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan

Jun Kido et al.

Summary: Liver transplantation is effective for long-term survival and prevention of recurrent hyperammonemia in UCDs patients. However, it has limited effect on improving neurodevelopmental outcomes, especially for patients with severe disease, as hyperammonemia at the onset time can significantly impact the brain. Patients with ASSD may have a higher chance of survival without cognitive impairment if they receive early LT despite having severe neonatal hyperammonemia.

JOURNAL OF INHERITED METABOLIC DISEASE (2021)

Article Endocrinology & Metabolism

OTC deficiency in females: Phenotype-genotype correlation based on a 130-family cohort

Stephanie Gobin-Limballe et al.

Summary: This study on females in OTC deficient families found that 22% of heterozygous females were clinically affected, with a higher risk of severe disease in females with severe mutations. Variability in OTC activity and X inactivation profile within the liver was observed, with little correlation between the two in most cases.

JOURNAL OF INHERITED METABOLIC DISEASE (2021)

Article Medicine, Research & Experimental

Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys

Julien Baruteau et al.

Summary: X-linked inherited ornithine transcarbamylase deficiency (OTCD) can lead to acute hyperammonemia despite current therapies, and liver transplantation is a curative option with risks. AAV vectors, specifically AAVLK03, were studied for treating OTCD in a non-human primate model and demonstrated safety and effectiveness in delivering the OTC gene to the liver.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Article Endocrinology & Metabolism

Evaluation of neurocognitive function of prefrontal cortex in ornithine transcarbamylase deficiency

Afrouz Anderson et al.

MOLECULAR GENETICS AND METABOLISM (2020)

Article Endocrinology & Metabolism

Retrospective evaluation of 85 patients with urea cycle disorders: one center experience, three new mutations

Ozlem Saritas Nakip et al.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2020)

Article Genetics & Heredity

Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency

Deyun Lu et al.

ORPHANET JOURNAL OF RARE DISEASES (2020)

Review Genetics & Heredity

Urea cycle disorders-update

Shirou Matsumoto et al.

JOURNAL OF HUMAN GENETICS (2019)

Article Endocrinology & Metabolism

Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision

Johannes Haberle et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2019)

Article Endocrinology & Metabolism

Challenges in diagnosing and managing adult patients with urea cycle disorders

Karolina M. Stepien et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2019)

Article Endocrinology & Metabolism

Perspectives on urea cycle disorder management: Results of a clinician survey

Gregory M. Enns et al.

MOLECULAR GENETICS AND METABOLISM (2019)

Article Endocrinology & Metabolism

Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders

Jochen Meyburg et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2018)

Article Biotechnology & Applied Microbiology

Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency

Mary G. Prieve et al.

MOLECULAR THERAPY (2018)

Review Endocrinology & Metabolism

Liver involvement in urea cycle disorders: a review of the literature

Adrien Bigot et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2017)

Article Endocrinology & Metabolism

Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects

Julien Baruteau et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2017)

Review Biochemistry & Molecular Biology

Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update

Ljubica Caldovic et al.

JOURNAL OF GENETICS AND GENOMICS (2015)

Review Genetics & Heredity

Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients

Anais Brassier et al.

ORPHANET JOURNAL OF RARE DISEASES (2015)

Article Pediatrics

Significant Hepatic Involvement in Patients with Ornithine Transcarbamylase Deficiency

Renata C. Gallagher et al.

JOURNAL OF PEDIATRICS (2014)

Article Endocrinology & Metabolism

A longitudinal study of urea cycle disorders

Mark L. Batshaw et al.

MOLECULAR GENETICS AND METABOLISM (2014)

Article Endocrinology & Metabolism

Investigating neurological deficits in carriers and affected patients with ornithine transcarbamylase deficiency

Courtney Sprouse et al.

MOLECULAR GENETICS AND METABOLISM (2014)

Article Endocrinology & Metabolism

Dietary management of urea cycle disorders: European practice

S. Adam et al.

MOLECULAR GENETICS AND METABOLISM (2013)

Article Endocrinology & Metabolism

Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium

Jennifer Seminara et al.

MOLECULAR GENETICS AND METABOLISM (2010)

Article Pediatrics

Hereditary urea cycle diseases in Finland

Paivi Keskinen et al.

ACTA PAEDIATRICA (2008)

Article Endocrinology & Metabolism

Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency

Katharina Engel et al.

MOLECULAR GENETICS AND METABOLISM (2008)

Review Endocrinology & Metabolism

Neurological implications of urea cycle disorders

A. L. Gropman et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2007)

Article Medicine, General & Internal

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders

Gregory M. Enns et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Endocrinology & Metabolism

The role of liver transplantation in urea cycle disorders

JV Leonard et al.

MOLECULAR GENETICS AND METABOLISM (2004)